April 28th 2025
Smoking prevalence is projected to decline by 2035, yet health consequences persist due to slower reductions among older adults.
What We’re Reading: Unpaid Medical Debt; COVID-19 and Hypertension; SNAP Work Requirement Changes
August 21st 2023About 17 million middle-class Americans have unpaid medical bills; more than 1 in 5 patients hospitalized with COVID-19 developed high blood pressure; work requirements for Supplemental Nutrition Assistance Program (SNAP) benefits to begin in September.
Read More
Dr Gustavo Fonseca on Key Takeaways From an FCS Analysis on Clinical Trial Enrollment
August 19th 2023Gustavo Fonseca, MD, FACP, physician director of clinical research, Florida Cancer Specialists & Research Institute (FCS), discusses the results from a late phase complexity analysis on barriers to clinical trials regarding biopsy requirements.
Watch
Study Validates PSA-Based Recurrence Definitions for Prostate Cancer Prognostication
August 19th 2023Researchers determined that the Huber et al. criteria regarding prostate-specific antigen (PSA) levels may more accurately predict the need for additional treatment or the possibility of treatment failure compared with other PSA-based definitions.
Read More
Quality vs Convenience: Rural Cancer Patients Weigh Options for Surgical Care
August 17th 2023“Our study suggests that narrowly focusing on hospital volumes and tying that to insurance reimbursement might mask complexities and trade-offs in achieving the goal of optimizing patient outcomes and experiences,” lead co-author Lindsay Sabik, PhD, says.
Read More
Standardizing Digital Health Interventions for Depression May Improve Patient Adherence, Study Finds
August 16th 2023Standardized reporting of patient adherence and engagement among digital health interventions for depression offers more effective comparisons between digital health tools and populations.
Read More
Race Not Independently Associated With Biologic Access for Psoriasis in the United States
August 16th 2023No significant differences regarding racial backgrounds were found when measuring access to biologics among adult patients with psoriasis living in the United States, according to one study.
Read More
Free Myeloperoxidase Levels Show Promise for Predicting Risk of Cardiovascular, All-Cause Mortality
August 12th 2023New research suggests that measuring the inflammatory marker myeloperoxidase (MPO) may be an effective strategy for the prediction of patients' risk of mortality in a myriad of cardiac—and potentially non-cardiac—diseases.
Read More